28 ott 2021

Elezioni coordinatori gruppi di studio - novembre 2021

Rinnovo del coordinatore dei gruppi di studio

20 ott 2021

Progetto TeleDerma – Attuale utilizzo ed opportunità offerte dai servizi di telemedicina in dermatologia in Italia

Stato dell’arte nell’utilizzo di soluzioni digitali di telemedicina in area dermatologica

19 ott 2021

Treatment challenges in clinically amyopathic dermatomyositis

The term clinically amyopathic dermatomyositis (CADM) is used to represent a subgroup of patients

19 ott 2021

Dermatological Manifestations in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBDs) may be associated with extra-intestinal manifestations.

19 ott 2021

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but they have not been adequately compared in clinical trials.

19 ott 2021

Fotoprotezione i nuovi orizzonti

Ne hanno parlato i dermatologi della SIDeMaST, riuniti in streaming al loro 95esimo Congresso.

16 ott 2021

AIFA - Consultazione dell’elenco degli apteni utilizzati nella pratica clinica

AIFA fornisce per consultazione pubblica, l'elenco degli apteni che risultano attualmente impiegati.

14 ott 2021

Ripresa dei trattamenti dopo la fase acuta del Covid

Durante la pandemia sempre più persone hanno abbandonato le cure con gravi ripercussioni sulle diagnosi. Bisogna quindi tornare a curarsi affidandosi alle cure del dermatologo, figura sempre più centrale nella terapia delle malattie della pelle che riunisce in sé tre competenze

14 ott 2021

Psoriasi e dermatite atopica indicazioni dei dermatologi

Le nuove chances terapeutiche per eliminare le lesioni cutanee e mitigare il prurito, al centro della seconda giornata di lavori del Congresso della Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse.

12 ott 2021

Customer Satisfaction 2021

Questionario di qualità

11 ott 2021

Phase 2a randomized clinical trial of dupilumab

Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited

11 ott 2021

Tildrakizumab for treatment of moderate to severe psoriasis

IntroductionTildrakizumab is a monoclonal antibody that targets the p19 subunit of IL-23, a crucial cytokine for Th17 cells.

11 ott 2021

Psoriatic arthritis incidence among patients receiving biologic medications for psoriasis

The objective of this study was to investigate the effect of biological treatments for psoriasis on the incidence of psoriatic arthritis.

05 ott 2021

A Randomized Double-Blind Parallel-Group Study

Actinic keratosis (AK) consists of skin lesions with a milder degree of keratinocytic atypia

05 ott 2021

Improvement in symptoms of anxiety and depression in patients

Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib

05 ott 2021

Surgical excision margins for fibrohistiocytic tumors

Mohs micrographic surgery or wide local excision is the treatment of choice for fibrohistiocytic tumors with metastatic potential

05 ott 2021

Feelings of guilt in parents of children with atopic dermatitis

Feelings of guilt may be associated with illness. Patients may feel responsible for their disease

27 set 2021

Dermoscopy, confocal microscopy and optical coherence tomography

Non-invasive skin imaging features of main skin inflammatory and autoimmune diseases have been reported, although a comprehensive review of their correlation with histopathologic features is currently lacking.

27 set 2021

Are the chilblain-like lesions observed during the COVID-19

The expansion of the COVID-19 pandemic has been accompanied by numerous reports of chilblain-like lesions (CLL) in different countries

27 set 2021

A practical guide on the use of imiquimod cream to treat lentigo maligna

Lentigo maligna (LM) is a common in situ melanoma subtype arising on chronically sun-damaged skin and mostly affects the head and neck region.